The novel finding of OTX2 oncogene gain in 42/108 (39%) WNT medulloblastomas was identified using molecular inversion probe (MIP) array technology and was associated with significantly worse progression free survival (PFS) and OS [3]. The gene discussed is OTX2; the disease is medulloblastoma.